Time to Insulin Therapy and Severe Hypoglycemia in Korean Adults Initially Diagnosed with Type 2 Diabetes: A Nationwide Study
Open Access
- 30 June 2025
- journal article
- Published by Korean Endocrine Society in Endocrinology and Metabolism
- Vol. 40 (3) , 421-433
Abstract
Background: We examined the distribution of time to insulin therapy (TIT) post-diabetes diagnosis and the hazard of severe hypoglycemia (SH) according to TIT in Korean adults initially diagnosed with type 2 diabetes (T2D) and who progressed to insulin therapy.Methods: Using data from the Korean National Health Insurance Service (2002 to 2018), we selected adult incident insulin users (initially diagnosed as T2D) who underwent health examinations between 2009 and 2012. The hazards of SH, recurrent SH, and problematic hypoglycemia were analyzed according to groups categorized using the TIT and clinical risk factors for SH (TIT ≥5 years with risk factors, TIT ≥5 years without risk factors, 3 ≤TIT <5 years, 1 ≤TIT <3 years, and TIT <1 year).Results: Among 41,637 individuals, 14,840 (35.64%) and 10,587 (25.43%) initiated insulin therapy within <5 and <3 years postdiabetes diagnosis, respectively. During a median 6.53 years, 3,406 SH events occurred. Compared to individuals with TIT ≥5 years and no risk factor for SH, individuals with TIT <3 years had higher outcome hazards in a graded manner (adjusted hazard ratio [95% confidence intervals] for any SH: 1.117 [0.967 to 1.290] in those with 3 ≤TIT <5 years; 1.459 [1.284 to 1.657] in those with 1 ≤ TIT <3 years; and 1.515 [1.309 to 1.754] in those with TIT <1 year). This relationship was more pronounced in the non-obese subpopulation.Conclusion: Among adults who progressed to insulin therapy after being diagnosed with T2D, a shorter TIT was not uncommon and may predict an increased risk of SH, particularly in non-obese patients.Keywords
Funding Information
- Ministry of Science and ICT
- Ministry of Trade, Industry and Energy
- Ministry of Health and Welfare
- Ministry of Food and Drug Safety
- Korea Medical Device Development Fund (RS-2020-KD000056)
This publication has 40 references indexed in Scilit:
- Type 1 diabetesThe Lancet, 2014
- Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapyDiabetes/Metabolism Research and Reviews, 2012
- First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in AsiaJournal of Diabetes, 2011
- A New Equation to Estimate Glomerular Filtration RateAnnals of Internal Medicine, 2009
- Beneficial Effects of Insulin on Glycemic Control and β-Cell Function in Newly Diagnosed Type 2 Diabetes With Severe Hyperglycemia After Short-Term Intensive Insulin TherapyDiabetes Care, 2008
- Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in DiabetesDiabetes, 2005
- Defining and Reporting Hypoglycemia in DiabetesDiabetes Care, 2005
- New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortalityJournal of Clinical Epidemiology, 2004
- C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve β-Cell FunctionDiabetes, 2004
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987